Status:
UNKNOWN
Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Lead Sponsor:
Bayside Health
Collaborating Sponsors:
Monash Medical Centre
National Institutes of Health (NIH)
Conditions:
HIV-hepatitis Co-infection
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
Data from this study will provide the first information how the innate immune system may be altered in HIV-HCV and HIV-HBV co-infected individuals, and describe Toll-like receptor changes with HIV co-...
Detailed Description
It has been demonstrated that Toll-like receptors (TLR) are involved in viral hepatitis - hepatitis B (HBV), hepatitis C (HCV) - and HIV in the setting of mono-infection. However the role of innate im...
Eligibility Criteria
Inclusion
- HIV and either HBV or HCV co-infection
- 18 years and older
- able to give informed consent
Exclusion
- HIV-HBV-HCV triple infection
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00662194
Start Date
April 1 2008
End Date
October 1 2014
Last Update
March 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Alfred Hospital
Melbourne, Victoria, Australia, 3004